Inactive Instrument

Press Releases Puma Biotechnology Inc OTC Bulletin Board

Equities

PBYI

US74587V1070

Real-time Estimate Cboe BZX Other stock markets 02:34:28 2024-06-26 pm EDT			5-day change	1st Jan Change
3.035 ^USD	0.00%		0.00%	0.00%

Jun. 02	Puma Biotechnology, Inc. Announces Presentation of Findings from A Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (Tbcrc 041)	CI
May. 17	Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	Jun. 07	BU
Puma Biotechnology : Corporate Presentation	Jun. 03	PU
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer	Jun. 03	BU
Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)	Jun. 02	BU
Puma Biotechnology to Join Russell 3000 Index	May. 28	BU
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting	May. 23	BU
Puma Biotech: Q1 Earnings Snapshot	May. 02	AQ
Puma Biotechnology Reports First Quarter Financial Results	May. 02	BU
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results	Apr. 18	BU
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(4)	Apr. 04	AQ
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	Apr. 03	BU
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	Mar. 20	BU
Puma Biotechnology : Corporate Presentation	Mar. 06	PU
Puma Biotech: Q4 Earnings Snapshot	Feb. 29	AQ
Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 29	BU
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	Feb. 27	BU
Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference	Feb. 22	BU
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results	Feb. 15	BU
Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer	Feb. 13	BU
Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference	Jan. 11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Puma Biotechnology Inc OTC Bulletin Board

Equities

PBYI

US74587V1070

Press Releases

Filters